Eurocine Vaccines AB (publ) reported earnings results for the third quarter and nine months ended March 31, 2021. For the quarter, the company has posted loss after tax during the period amounted to SEK 4.6 million against SEK 2 million a year ago. Revenues during the period amounted to SEK 75,000 against SEK 8,000 a year ago. Loss per share during the period SEK 0.582 against SEK 0.006 a year ago. For the nine months, the company has posted loss after tax during the period amounted to SEK 12,2 million against SEK 6,7 million. Revenues during the period amounted to SEK 457,000 against SEK 8,000 a year ago. Loss per share during the period amounted to SEK 1.544 against SEK 0.03 a year ago.